Tesai Care — Seed (estimated) · €2.77M incl. debt: equity and debt, the split was not disclosed

Tesai Care, a spin-off of the Parc Taulí and Vall d'Hebron research institutes, disclosed €2.77M combining private and public money — Nara Capital on the private side plus CDTI-Innvierte, the Institut Català de Finances, ENISA Emprendedoras Digitales and a Women TechEU grant — with no single lead named. The capital funds clinical trials of heecap, a non-invasive electrostimulation device to prevent respiratory muscle atrophy in ICU patients, targeting CE marking in 2026.